ATX-101 for Post-surgical Pain Following Total Knee Arthroplasty
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This is a Phase 2B randomized, double blind, placebo and active controlled, multi-center
clinical trial to evaluate the safety and efficacy of ATX-101 in participants following total
knee arthroplasty.